Direct Thrombin Inhibitor [EPC]

2449 reported adverse events

Drugs of this class: ARGATROBAN BIVALIRUDIN HAMAMELIS AESCULUS

These side effects are most commonly reported by patients taking drugs of the Direct Thrombin Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 344
1 HEPARIN-INDUCED THROMBOCYTOPENIA 259
2 OFF LABEL USE 207
3 HAEMORRHAGE 172
4 INTERNATIONAL NORMALISED RATIO INCREASED 114
5 THROMBOSIS 98
6 THROMBOCYTOPENIA 95
7 GASTROINTESTINAL HAEMORRHAGE 93
8 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 84
9 DEEP VEIN THROMBOSIS 81
See all common reactions for Direct Thrombin Inhibitor [EPC]

Drugs of the Direct Thrombin Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 8 0.1270
1 HEPARIN-INDUCED THROMBOCYTOPENIA 259 0.0525
2 COAGULATION TIME PROLONGED 77 0.0497
3 COAGULATION TIME ABNORMAL 12 0.0400
4 ILIAC ARTERY OCCLUSION 9 0.0327
5 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 8 0.0324
6 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 10 0.0239
7 VASCULAR STENT THROMBOSIS 47 0.0231
8 CARDIAC PROCEDURE COMPLICATION 13 0.0214
9 HAEMORRHAGIC CEREBRAL INFARCTION 14 0.0199
See all enriched reactions for Direct Thrombin Inhibitor [EPC]